About Multisystem Inflammatory Syndrome in Children (MIS-C)
The disease causes of multisystem inflammatory syndrome in children (MIS-C) are still being studied, but it is believed to be associated with an imbalanced immune response to SARS-CoV-2, the virus that causes COVID-19. The exact mechanisms are not fully understood, but it is thought that the virus triggers an immune response that leads to widespread inflammation in various organs and systems of the body.
Non-modifiable risk factors for MIS-C cannot be changed or controlled. These include:
- Age: Children between the ages of 5 and 13 appear to be at higher risk.
- Gender: Boys seem to be more commonly affected by MIS-C than girls.
- Race: Black and Hispanic children have been found to have a higher risk of developing MIS-C, possibly due to healthcare gaps.
On the other hand, modifiable risk factors refer to factors that can be influenced or changed. While there is limited information on specific modifiable risk factors for MIS-C, maintaining a healthy lifestyle and following preventive measures against COVID-19, such as practicing good hygiene, wearing masks, and social distancing, may help reduce the risk.
Remember, MIS-C is a serious condition that requires medical attention. If you suspect your child may have MIS-C or have any concerns, it is important to consult with a healthcare professional for an accurate diagnosis and appropriate management.
The most common early symptoms of multisystem inflammatory syndrome in children (MIS-C) include:
- Fatigue
- Shortness of breath
- Cognitive dysfunction (trouble with thinking, memory, or focus)
As the condition progresses or becomes more severe, other common symptoms that may occur include:
- Gastrointestinal symptoms such as abdominal pain, vomiting, and diarrhea
- Mucocutaneous involvement (involvement of the skin and mucous membranes)
- Neurologic symptoms such as headache and irritability
- Conjunctivitis (pink eye)
- Cardiac complications, including left ventricular dysfunction and cardiovascular shock
It's important to note that MIS-C can affect multiple organ systems, leading to potentially life-threatening complications such as multi-organ failure. Early diagnosis and treatment are crucial for managing this condition. If you suspect your child may have MIS-C or if they are experiencing any concerning symptoms, it's important to seek medical attention promptly.
To diagnose multisystem inflammatory syndrome in children (MIS-C) or COVID-19-associated multisystem inflammatory syndrome in children, healthcare professionals commonly perform the following examinations, tests, and procedures:
- Medical history and physical exam: The doctor will collect your child's medical history, ask about symptoms, and inquire about recent COVID-19 exposure or infection.
- Blood tests: These tests measure markers of inflammation, such as C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), which can indicate the presence of MIS-C.
- Urine tests: These tests may be done to assess kidney function and look for signs of inflammation.
- Ultrasound of the abdomen: This imaging test can help evaluate the organs in the abdomen for any signs of inflammation or damage.
- X-rays of the chest: These images can reveal any abnormalities in the lungs or heart.
- Electrocardiogram (EKG) or ultrasound of the heart: These tests assess the function and structure of the heart, as cardiac complications are common in MIS-C.
To determine the stage or severity of MIS-C, additional examinations, tests, and procedures may include:
- Repeat blood tests to monitor inflammatory markers and organ function.
- Additional imaging studies, such as echocardiogram (ultrasound of the heart) or MRI (magnetic resonance imaging), to assess organ involvement.
- Close monitoring of vital signs, including blood pressure, heart rate, and body temperature.
- Evaluation by specialists in cardiology, infectious diseases, and other relevant fields to guide treatment decisions.
Remember that only a medical doctor can diagnose MIS-C, so it's important to seek immediate medical attention if you suspect your child may have this condition.
The goals of treatment for multisystem inflammatory syndrome in children (MIS-C) or COVID-19-associated multisystem inflammatory syndrome in children are:
- Control inflammation: The main goal is to reduce the excessive inflammation in the body. This is typically achieved through the use of intravenous immunoglobulin (IVIG) and steroids as first-line treatments. IVIG helps regulate the immune response, while steroids have anti-inflammatory properties.
- Supportive care: Children with MIS-C may require supportive care to manage symptoms and complications. This includes close monitoring of vital signs, hydration, and nutrition support.
- Anticoagulation therapy: In some cases, therapeutic anticoagulation may be recommended for children with MIS-C who have large coronary artery aneurysms or moderate-to-severe left ventricular dysfunction. This helps prevent blood clots and related complications.
- Future therapeutics: Antagonists of certain cytokines are being explored as potential future therapeutics for MIS-C. These medications target specific inflammatory molecules to help control the immune response.
- Natural compounds: Some research suggests that natural compounds with antioxidant and anti-inflammatory effects could be used as complementary treatments for MIS-C. However, further research is needed to determine their safety and effectiveness.
It's important to note that treatment for MIS-C should be individualized based on each patient's condition and expert opinion. Always consult with a healthcare professional for personalized treatment recommendations.
Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Side effects can occur. Check with your health care professional or read the information provided with your medication for side effect information.